Imaging and treatment of pathophysiologic conditions by Cerenkov radiation
AssigneeWashington University
InventorsSamuel Achilefu, Nalinikanth Kotagiri
Life of this patent
Estimating the term…
Abstract
The present disclosure discloses methods and compositions for administering Cerenkov radiation-induced therapy (CRIT).
Claims19
A composition, comprising a photoinitiator, one or more photosensitizers and a targeting agent, wherein the photoinitiator is titanocene or titanocene dichloride and the targeting agent is albumin.
A method for treating a cancer or tumor in a subject in need thereof, the method comprising:
- a) administering to the subject a composition comprising a photoinitiator and a targeting agent, wherein the photoinitiator is titanocene or titanocene dichloride and the targeting agent is albumin;
- and
- b) administering concurrently or subsequently to the subject a composition comprising an amount of a radionuclide effective to activate the composition in step a), thereby treating the cancer or tumor.
A composition, comprising a photoinitiator, at least one radionuclide and a targeting agent, wherein the photoinitiator is titanocene or titanocene dichloride and the targeting agent is albumin.
Dependencies are inferred from the claim text.